Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00060021 · ClinicalTrials.gov registry record · NA

Acupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell Transplantation

A NA study of Cancer, sponsored by National Cancer Institute (NCI).

Completed
Registry status
NA
Development phase
1
Study location

NCT00060021: Completed NA study of Cancer, sponsored by National Cancer Institute (NCI).

NCT00060021 is a NA study of Cancer that has completed, run by National Cancer Institute (NCI). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00060021, a NA study of Cancer, has completed, sponsored by National Cancer Institute (NCI).

COMPLETED
Registry status
NA
Development phase
1
Study location

Study Summary

RATIONALE: Acupuncture may be effective in relieving mucositis-related pain caused by chemotherapy in patients undergoing stem cell transplantation. PURPOSE: Randomized clinical trial to study the effectiveness of acupuncture in treating mucositis-related pain caused by high-dose chemotherapy in patients who are undergoing stem cell transplantation.

Conditions Studied

Interventions

  • PROCEDURE management of therapy complications
  • PROCEDURE acupuncture therapy
  • PROCEDURE pain therapy

Study Locations (1)

Maryland

  • Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support - Bethesda

Trial Details

FieldValue
Start Date 2003-03
Phase NA

Sponsor

National Cancer Institute (NCI)

3,257 total trials

What the Registry Record Tells You About NCT00060021

The ClinicalTrials.gov registry entry for NCT00060021 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 3 interventions - of which management of therapy complications is the first listed.

NCT00060021 reports 1 study location spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT00060021 about?

NCT00060021 is a clinical study titled "Acupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell Transplantation". RATIONALE: Acupuncture may be effective in relieving mucositis-related pain caused by chemotherapy in patients undergoing stem cell transplantation. PURPOSE: Randomized clinical trial to study the effectiveness of acupuncture in treating mucositis-related pain caused by high-dose chemotherapy in pa...

What is the current status of trial NCT00060021?

This trial is currently completed. It is a NA study. The study started on 2003-03.

What conditions does trial NCT00060021 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT00060021?

The interventions under investigation include: management of therapy complications (PROCEDURE), acupuncture therapy (PROCEDURE), pain therapy (PROCEDURE).

Who is sponsoring clinical trial NCT00060021?

This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00060021 being conducted?

This trial has 1 study location across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.